Advertisement

Reshma Jagsi, MD, DPhil, FASCO, Named New Chair of Emory Radiation Oncology


Advertisement
Get Permission

Reshma Jagsi, MD, DPhil, FASCO

Reshma Jagsi, MD, DPhil, FASCO

Reshma Jagsi, MD, DPhil, FASCO, recently joined Emory School of Medicine as Chair of the Department of Radiation Oncology. Dr. Jagsi was formerly the Newman Family Professor, Deputy Chair, and Residency Program Director in the Department of Radiation Oncology and Director of the Center for Bioethics and Social Sciences in Medicine at the University of Michigan.

Professional Background

Before beginning her faculty career at the University of Michigan, Dr. Jagsi completed undergraduate and medical training at Harvard and her second doctorate in social policy at the University of Oxford as a Marshall Scholar. Internationally recognized for her research in both breast cancer and bioethics, she is the author of more than 400 articles in peer-reviewed journals, including multiple high-impact studies in journals such as The New England Journal of Medicine, TheLancet, and JAMA. Her research in both breast cancer and bioethics has been funded by R01 grants from the National Institutes of Health as well as large independent grants from numerous philanthropic foundations.

Awards and Honors

In recognition of her contributions, Dr. Jagsi has been elected to the American Society of Clinical Investigation and Association of American Physicians, the Leadership Award of the Association of American Medical Colleges Group on Women in Medicine and Science, LEAD Oncology’s Woman of the Year Award, the American Medical Women’s Association Woman in Science Award, and the American Medical Students Association Women Leaders Award. She is a fellow of ASCO, the American Society for Radiation Oncology (ASTRO), and the Hastings Center, and this year she will be one of two recipients of ASTRO’s inaugural Mentorship Award.

“I could not be more excited about joining the extraordinary team at Emory and having the opportunity to build its department of radiation oncology from excellence to eminence,” said Dr. Jagsi. 


Advertisement

Advertisement




Advertisement